Greenwich Lifesciences Inc (GLSI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 4,092 | 5,822 | 7,225 | 5,506 | 6,989 |
| TOTAL | $4,092 | $5,822 | $7,225 | $5,506 | $6,989 |
| Non-Current Assets | |||||
| Intangibles | 2 | 3 | 4 | 5 | 5 |
| TOTAL | $2 | $3 | $4 | $5 | $5 |
| Total Assets | $4,094 | $5,825 | $7,229 | $5,511 | $6,995 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,803 | 775 | 1,335 | 347 | 256 |
| Other current liabilities | 76 | 68 | 18 | 43 | 38 |
| TOTAL | $3,185 | $842 | $1,353 | $390 | $294 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 306 | N/A | N/A | N/A | N/A |
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $3,185 | $842 | $1,353 | $390 | $294 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 13,274 | 13,145 | 13,145 | 12,880 | 12,878 |
| Common Shares | 13 | 13 | 13 | 13 | 13 |
| Retained earnings | -67,779 | -58,113 | -55,445 | -52,838 | -50,365 |
| TOTAL | $909 | $4,983 | $5,875 | $5,121 | $6,700 |
| Total Liabilities And Equity | $4,094 | $5,825 | $7,228 | $5,511 | $6,995 |